Home › Metastatic Cancer › Minnesota › Saint Paul
Metastatic Cancer clinical trials in Saint Paul, MN
7 studies for Metastatic Cancer are looking for participants at sites in and around Saint Paul (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Saint John's Hospital - Healtheast, Maplewood · 5 mi away
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RecruitingPhase 1
- HealthPartners Cancer Research Center, Saint Paul
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecruitingPhase 3
- Research Site, Saint Paul
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi away
- Minnesota Oncology Hematology, P.A., Woodbury · 7 mi away
- and 1 more
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi away
- Minnesota Oncology Hematology, P.A., Woodbury · 7 mi away
- Minnesota Oncology Hematology, P.A., Hudson · 17 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- HealthPartners Cancer Research Center, Saint Paul
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RecruitingPhase 1
- HealthPartners Cancer Research Center, Saint Paul
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Saint Paul
- Non-Small Cell Lung Cancer19 studies
- Prostate Cancer13 studies
- Lung Cancer13 studies
- Breast Cancer12 studies
- Colorectal Cancer9 studies
- Ovarian Cancer8 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Endometrial Cancer6 studies
- Bladder Cancer6 studies
- Melanoma6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Acute Myeloid Leukemia6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.